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Edited by Ulrike KutayAbstract It has generally been believed that the diﬀusion limit
set by the nuclear pore for protein is 60 kDa. We here studied
the cellular localization of several artiﬁcial proteins and found
that the diﬀusion limit set by the nuclear pore is not as small
as previously thought. The results indicate that the maximal size
of protein to diﬀuse through the nuclear pore complex could be
quite larger than 60 kDa, thus greatly extending the diﬀusion
limit that the nuclear pore can accommodate.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The nucleus is separated from the cytoplasm by a double
membrane called the nuclear envelope (NE) in eukaryotes.
The NE is penetrated by nuclear pore complexes (NPCs),
through which the cytoplasm communicates with the nucleus
and permits exchange of contents between the two organelles.
With improvements in detection methods and instrumentation,
the structure of the NPC has been reﬁned over the years. It has
been shown that the overall structure is similar in diﬀerent spe-
cies and is thus believed to be conserved in all eukaryotes [1].
The NPC is a huge structure of around 120 million Daltons
in size and is constructed from 30 diﬀerent proteins that
are often called nucleoporins [2–4]. The canonical feature of
the NPC includes the central plug/transporter(CP/T), three
rings with cytoplasmic ﬁlaments attached to the cytoplasmic
ring and a basket in the nuclear sides of the NPC. The diam-
eter of the cytoplasmic, lumenal spoke and distal ring deter-
mined by the latest studies is around 125 nm, 60 nm and
40 nm, respectively [5].
All nuclear proteins are made in the cytoplasm and must be
translocated into the nucleus, while RNA products, includingAbbreviations: NPC, nuclear pore complex; ERK2, extracellular
signal-regulated kinase 2; PDK1, 3 0-phosphoinositide-dependent
kinase; aa, amino acid(s); NLS, nuclear localization signal; NES,
nuclear export signal
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ger RNA (mRNA), are transcribed in the nucleus and
subsequently exported to the cytoplasm for protein synthe-
sis. Currently, the exchange of cytoplasmic and nuclear con-
tents is believed to mainly involve two processes: (1) passive
diﬀusion; and (2) an active process that is coupled to energy
input. Both processes are mediated through NPCs. For more
than two decades, it has generally been believed that for
proteins to passively diﬀuse through the nuclear membrane,
the limit set by the NPC is about 9–12 nm in diameter [6–8].
This was later interpreted to allow for the diﬀusion of pro-
teins with a maximal size of 60 kDa [9–14]. Alternatively, pro-
teins may shuttle between the cytoplasm and the nucleus in an
active way that is mediated by nuclear localization signals
(NLSs) or nuclear export signals (NESs). These signals are spe-
ciﬁcally recognized by corresponding adaptor proteins,
dubbed as importins and exportins that chaperon the
transported proteins into or out of the nucleus, respectively
[12,15].
We have repeatedly observed the nuclear localization of a
GFP3 oligomer protein, whose size is around 90 kDa. This
phenomenon contradicts the long-term view that the maximal
size for protein diﬀusion through the nuclear pore is around
60 kDa and it stimulates us to revisit the diﬀusion limit set
by the NPC. For this study, the cellular localization of three
artiﬁcial chimeric proteins was investigated. The results reveal
that proteins with sizes from 90 to 110 kDa are allowed to dif-
fuse through the nuclear pore, which may vary with diﬀerent
proteins studied. Thus, the capability of the nuclear pore for
allowing macromolecules to diﬀuse through is greatly in-
creased. In addition, this study does not exclude that the nucle-
ar pore allows the diﬀusion of proteins that are even larger
than those used in this study.2. Materials and methods
2.1. Cell culture and transfection
Human cervical cancer cell line HeLa, prostate cancer cell line
DU145 and lung cancer cell line A549 were cultured in Dulbecco’s
modiﬁed Eagle medium (DMEM) supplemented with 10% FBS. Hu-
man melanoma cell line Colo38 was cultured in RPMI1640 supple-
mented with 10% FBS. Human colon cancer cell line HCT116 was
cultured in McCoy’s 5a medium supplemented with 10% FBS. All cells
were cultured at 37 C in a humidiﬁed incubator containing 6% CO2.
Experiments involving transient transfection were conducted with
exponentially growing cells. Transfections of cells were conducted
using Lipofectamine 2000 as described by the manufacturer (Invitro-
gen).blished by Elsevier B.V. All rights reserved.
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The vector pEGFP-C1 (from Clontech, Inc.) was used for GFP1
protein expression. The plasmid expressing GFP5 was as described
previously [16]. The constructs expressing GFP2, GFP3 and GFP4
were generated by cutting the corresponding GFP portions from the
parental vector for expression of GFP5 and ligating into pcDNA
3.1+ vector (Invitrogen). In addition, the constructs expressing chime-
ric proteins based on Myc-ERK2 or Myc-PDK1 were made in the
pcDNA 3.1+ vector. Myc-ERK2 was created by polymerase chain
reaction (PCR) using a 5 0 oligonucleotide encoding the Myc-tag se-
quence (EQKLISEEDL) in addition to the extracellular signal-regu-
lated kinase 2 (ERK2) sequence. The resulting product was
subcloned into EcoRV and Xba1 sites of the vector. Myc-PDK1 was
provided by Dr. Alessi (University of Dundee, UK). All the constructs
expressing chimeric proteins based on Myc-ERK2 or Myc-PDK1 were
generated based on PCR method.
2.3. SDS–PAGE and Western blot
At 16 h after transfection, cells were lysed in lysis buﬀer (150 mM
NaCl, 5 mM EDTA, 50 mM NaF, 1% Nonidet P-40, 1 mM PMSF,
1 mM Na3VO4) with brief vortexing. After incubation on ice for
30 min, the supernatants were collected by centrifugation at maximal
speed for 10 min. Lysates were dissolved in 2· sample buﬀer
(100 mM Tris–HCl, pH 6.8, 2% SDS, 20% glycerol, 0.03% bromophe-
nol blue and 1.5% b-mercaptoethanol). Samples were subjected to
SDS–PAGE followed by transferring to PVDF membranes. Mem-
branes were blocked with TTBS (20 mM Tris–HCl, pH 7.0, 0.5 M
NaCl, 0.05% Tween-20) containing 5% non-fat milk for 2 h. After blot-
ting with speciﬁc primary antibodies and washing with TTBS, the
membranes were then incubated with peroxidase-conjugated goat
anti-mouse or anti-rabbit IgG (Jackson ImmunoResearch Laborato-
ries, Inc) and the resulting signals were visualized by ECL detection
(Amersham).
2.4. Immunoﬂuorescence
Cells were grown on 6 well dishes containing coverslips, ﬁxed in 2%
formaldehyde/PBS at 4 C for 1 h, and permeabilized in 0.2% Triton/
PBS for 10 min. After washing once with PBS, the cells were blocked
with 10% horse serum/PBS for 40 min and washed once again with
PBS. The coverslips were then incubated with 4 lg/ml primary anti-
body/PBS at room temperature for 1 h followed by washing with
PBS. The primary antibody against Myc tag was 9E10 from Santa
Cruz Biotechnology, Inc. The samples were further blocked with rho-
damine-conjugated goat anti-mouse immunoglobulin G antibody
(Jackson ImmunoResearch Laboratories) for 1 h (1:100 dilution).
The coverslips .were stained with 4,6-diamidino-2-phenylindole
(DAPI) and were washed twice with PBS. The coverslips were
mounted on glass slides with Aquamount (Polyscience, Inc., Warring-
ton, PA). Images were captured under ﬂuorescent microscopy using
the indicated ﬁlter with a Hamamatsu 16-bit digital camera mounted
on a Zeiss Axioplan microscope using a 63· objective and processed
with Adobe Photoshop software.3. Results and discussion
To determine the size limit for proteins that are able to dif-
fuse through the nuclear pore, serial constructs for GFP oligo-
mer fusion proteins were made, which include GFP1, GFP2,
GFP3, GFP4 and GFP5. The GFPs are expressed in frame
with each other and the number indicates the number of
GFP proteins that are fused together (Fig. 1A). When these
GFP fusion proteins were expressed, their molecular weights
ranged from 28 kDa to 140 kDa (GFP1–GFP5, respectively)
(Fig. 1B). When the localization of these fusion proteins was
determined in HeLa cells after transient transfection for 8 h,
it was found that GFP1, GFP2 and GFP3 were capable of
translocating into the nucleus of essentially all the transfected
cells, while GFP5 was predominantly localized in the cyto-
plasm (Fig. 1C). GFP4 protein was detected in the nucleus
of most transfected cells (90%), while it could be sparsely de-tected to be localized in the cytoplasm (10%). This implied
that the size of GFP4 protein is very near to or exceeds the dif-
fusion limit set by the nuclear pore, though most of the protein
is still able to ‘‘squeeze’’ through the nuclear pore. In addition,
it was found that in the cells transfected with GFP1, GFP2 and
GFP3, most of them demonstrated a higher GFP nuclear
staining when compared to that of the cytoplasm (Fig. 1C).
These results are consistent with previous observations that
the nucleus generally demonstrates a higher ﬂuorescent stain-
ing than the cytoplasm of the small diﬀusion proteins in ﬁxed
cells [17,18]. In contrast, the distribution of GFP signal in the
cytoplasm was very similar to that in the nucleus of the GFP4
transfectants and the distinction of the nucleus from the cyto-
plasm became unclear in many cells (Fig. 1C), suggesting that
protein nuclear translocation is a relative slow process and be-
comes ineﬃcient as the protein size increases to that of GFP4
protein. In a separate experiment (data not shown), cells were
ﬁxed every one half hour after transfection with GFP3 or
GFP4. Due to the time it took DNA to enter the cells and
its subsequent transcription and translation, the GFP signal
was barely detectable after 2 h transfection. Only after 2.5 h
were the cells bearing the GFP signal clearly identiﬁed in both
type of transfectants. GFP3 transfectants already demon-
strated obvious nuclear localization by this time, indicating
the nuclear translocation of GFP3 protein is a relatively eﬃ-
cient process. In contrast, the nuclear translocation of GFP4
protein could only be rarely identiﬁed after 3.5 h and most
GFP4 transfectants still demonstrated a cytoplasmic localiza-
tion pattern, demonstrating that the nuclear translocation of
GFP4 protein is a relative slow process.
It is well established that GFP1 protein is able to diﬀuse into
the nucleus due to its small size and GFP1 itself does not con-
tain an NLS, otherwise GFP5 will be translocated into the nu-
cleus too. The above results indicated that in order for protein
to passively diﬀuse through the NPC, its size does not need to
be smaller than 60 kDa as established before. In contrast, large
proteins, such as GFP3 and GFP4, whose size are around 90
and 110 kDa respectively, are able to diﬀuse into the nucleus,
though the process becomes less eﬃcient as the protein size in-
creases to that of GFP4.
To extend this study, additional cell lines were investigated
(HCT116, colo38, DU145 and A541 cells). Interestingly,
although GFP3 was still eﬀectively translocated into the nu-
cleus and GFP5 was predominantly localized in the cytoplasm
of all the cell lines studied, the eﬃciency of the GFP4 nuclear
translocation varied among the diﬀerent cell lines. For exam-
ple, it appears that the GFP4 is much poorer at diﬀusing
through the nuclear pore in HCT116 cells than in HeLa cells
and is mainly restricted to the cytoplasm. The small discrep-
ancy of the cellular distribution pattern of GFP4 in diﬀerent
cell lines reﬂects that there is a subtle diﬀerence on the diﬀusion
limit set by the NPCs in diﬀerent cells studied, which is consis-
tent with previous observations [7].
To further disprove that the nuclear pore only allows the dif-
fusion of proteins with a maximal size of 60 kDa, the nuclear
translocation of ERK2 protein was studied. ERK2 is a mem-
ber of mitogen-activated protein (MAP) kinase family that
regulates many cellular events, such as cell proliferation and
diﬀerentiation [19,20]. ERK2 has frequently been reported to
be localized in the nucleus of many cell lines. Due to its small
size (42 kDa), it is generally believed that ERK2 can be trans-





















Fig. 1. Mapping of the largest chimeric GFP protein that is allowed to diﬀuse through the nuclear pore. (A) Schematic representation of chimeric
GFP oligomer proteins. (B) Western blot showing expression and migration of chimeric GFP oligomer proteins. Lysates were collected at 16 h after
transfection with the indicated constructs in HEK293 cells and the molecular weights of the transfected proteins were determined by Western blot
with mouse antibody against GFP. (C) The cellular localization of the chimeric GFP proteins was visualized at 8 h after transient transfection with
indicated constructs in HeLa cells.
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ar translocation. In recent studies of the nuclear translocation
of ERK2, GFP was fused with ERK2 to generate a fusion pro-
tein larger than 60 kDa (70 kDa). Consequently, this fusion
protein was interpreted as not being able to diﬀuse through
the nuclear pore [21,22]. Interestingly, these studies found that
the nuclear translocation of GFP-ERK2 is independent of any
transport factors and ATP. Based on these results, we specu-
late that the underlying mechanism of GFP-ERK2 nuclear
translocation is actually by diﬀusion. To test whether any
other mechanism was responsible for ERK2 nuclear transloca-
tion, ERK2 was fused with GFP5, which is a cytoplasmic pro-
tein as shown above. If ERK2 could be transported into the
nucleus via an active process, GFP5-ERK2 should be trans-
ported into the nucleus too. The results showed that the cellu-
lar localization of GFP5-ERK2 was predominantly localized
in the cytoplasm. As a positive control, a classical NLS was
able to concentrate GFP5 in the nucleus (Fig. 2A). Thus, the
possibility that an additional mechanism was responsible for
ERK2 nuclear translocation is excluded.To further test the maximal size allowed to diﬀuse through
the nuclear pore, serial chimeric Myc-tagged ERK2 fusion
proteins were made, whereby various additional lengths of
Myc-ERK2 were fused with one another at the N-terminus
(Fig. 2B). When expressed, the molecular weight of these chi-
meric proteins ranged from 86 kDa to 110 kDa (Fig. 2C).
When the cellular localization of these proteins was studied
(Fig. 2D), it was found that the Myc-ERK2x2 with a molecu-
lar weight of 86 kDa was translocated into the nucleus in
essentially all of the transfected cells, thus conﬁrming that
the nuclear pore allows the translocation of proteins larger
than 60 kDa. The extension of the fusion protein with an addi-
tional 50 amino acids (aa) (Myc-ERK2x2+50 aa) did not
change the nuclear localization pattern of this chimeric pro-
tein. In contrast, the addition of 100aa (Myc-ERK2x2+100 aa)
resulted in the restricted expression of protein in the cytoplasm
in some cells (5–10%), though most protein could still be trans-
ported into the nucleus of the majority of the transfectants.
The nuclear translocation eﬃciency was further greatly re-
duced in the protein containing additional 200 aa (Myc-
Fig. 2. Mapping of the maximal size of protein based on ERK2 that is allowed to diﬀuse through the nuclear pore. (A) The cellular localization of
the GFP5 fusion proteins was visualized at 8 h after transient transfection with indicated constructs in HeLa cells. (B) Schematic representation of
chimeric ERK2 fusion proteins. (C) Western blot showing expression and migration of chimeric ERK2 fusion proteins. Lysates were collected at 16 h
after transfection with the indicated constructs and the molecular weights of the transfected proteins were determined by Western blot with mouse
antibody against Myc tag. (D) The cellular 14 localization of the chimeric fusion proteins based on Myc-ERK2 was visualized at 8 h after transient
transfection with indicated constructs.
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size allowed to diﬀuse through the nuclear pore is between that
of Myc-ERK2x2+100 aa and Myc-ERK2x2+200 aa (98 and
110 kDa, respectively).
Lastly, as another conﬁrmation that nuclear pore is able to
allow the diﬀusion of proteins with a size of 90 kDa, serial
artiﬁcial proteins based on 3 0-phosphoinositide-dependent ki-
nase 1 (PDK1) were made. PDK1 is a 70 kDa protein com-
prised of a Ser/Thr kinase domain near the N-terminus and a
C-terminal pleckstrin homology (PH) domain [23]. PDK1 has
been proposed as a master AGC kinase that is able to phos-
phorylate AKT, p70 ribosomal S6 kinase, protein kinase
C(S6K), serum- and glucocorticoid-stimulated protein kinase
(SGK) and p90 ribosomal S6 kinase (RSK) [24]. It has been
found that PDK1 is mainly localized in the cytoplasm due to
the presence of a nuclear export signal. Consistent with previ-
ous results [25], PDK1 was redistributed to both the nucleus
and the cytoplasm after a small deletion of this nuclear export
signal in PDK1(Myc-PDK1DNES) (Fig. 3A). To determine
whether the nuclear translocation of Myc-PDK1DNES is med-
iated by a nuclear localization signal, PDK1DNES was fused
with the cytoplasmic protein, GFP5. It was found that
GFP5-PDK1DNES is primarily localized in the cytoplasm,thus the possibility that PDK1 contains a nuclear localization
signal was excluded (data not shown). In addition, the nuclear
localization of Myc-PDK1DNES implies that the nuclear pore
at least allows the diﬀusion of Myc-PDK1DNES protein,
which is a 70 kDa protein. To further map the maximal size
of protein that is based on the PDK1DNES and is allowed to
diﬀuse across the nuclear pore, various lengths of the N-termi-
nal Myc-PDK1DNES were fused to the N-terminus of another
Myc-PDK1DNES (Fig. 3B). These constructs expressed fusion
proteins ranging from 83 kDa to 120 kDa (Fig. 3C). When the
cellular localization of these proteins was determined
(Fig. 3D), it was found that the fusion proteins containing
an additional 100 or 135 amino acids to the N-terminus of
Myc-PDK1DNES (Myc-PDK1DNES+100 aa or Myc-
PDK1DNES+135 aa) (83 kDa and 88 kDa respectively) were
transported into the nucleus of all the transfected cells. In con-
trast, the addition of 200 amino acids, which corresponds to a
fusion protein of 92 kDa, restricted the fusion protein mainly
to the cytoplasm and similar results were observed when addi-
tional 300 or 400 (not shown) amino acids were fused to
Myc-PDK1DNES. These results indicated that in order to
diﬀuse through the nuclear pore, the maximal size of the
fusion proteins derived from PDK1 is between that of
Fig. 3. Mapping of the maximal size of protein based on PDK1 that is allowed to diﬀuse through the nuclear pore. (A) The cellular localization of
the wt or mutant PDK1 protein was visualized at 8 h after transient transfection with indicated constructs. (B) Schematic representation of chimeric
PDK1 fusion proteins. (C) Western blots showing expression and migration of chimeric PDK1 fusion proteins. Lysates were collected at 16 h after
transfection with the indicated constructs and the molecular weights of the transfected proteins were determined by Western blot with mouse
antibody against Myc tag. (D) The cellular localization of the chimeric fusion proteins based on Myc-PDK1DNES was visualized at 8 h after
transient transfection with indicated constructs. (A) Myc-PDK1DNES+100 aa; (B) Myc-PDK1DNES+135 aa; (C) Myc-PDK1DNES+200 aa; (D)
Myc-PDK1DNES+300 aa.
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which are 88 kDa and 92 kDa, respectively. Again, these
results conﬁrmed the previous observations that proteins of
90 kDa could diﬀuse through the nuclear pore.Consequently, this study reveals that the nuclear pore allows
the diﬀusion of protein with size of 90–110 kDa, which is dif-
ferent from the long established view that proteins need to be
smaller than 60 kDa to diﬀuse through the nuclear pore. Due
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in vivo, there is no doubt that the maximal size of the protein
that is allowed to diﬀuse through the nuclear pore could be dif-
ferent. For the same reason, currently we are not excluding the
possibility that the nuclear pore allows the diﬀusion of proteins
that are even larger than 110 kDa as in this study, which have
a more compact structure than those of the chimeric proteins
used in this study. Another possibility is that the protein is
asymmetric shaped, such as rod-shaped and therefore diﬀuses
through the nuclear pore end on [26]. Moreover, as mentioned
previously, this issue could be further complicated by that sub-
tle diﬀerences of the nuclear pore complex may exist between
cells originated from diﬀerent types or species
Protein nuclear translocation has been intensively studied
since 1960s. In the early period of these studies, most investi-
gations were done by using colloidal gold particles, dextrans
or the limited choices of proteins, such as insulin, ovalbumin
and bovine serum albumin (BSA) [6–8,26–31]. Based on the
nuclear translocation studies on colloidal gold particles and
dextrans [6–8], the maximal diameter of the nuclear pore was
estimated to be around 9–12 nm. During this similar period,
BSA (67 kDa) has been frequently used in the studies of pro-
tein nuclear translocation and was reported to be very ineﬃ-
ciently transported into the nucleus [6,26,30,31]. Although
other proteins with a similar size as BSA (60–100 kDa) have
seldom been tested in this early period and contradicting cases
have only sporadically been reported since then [32,33], it
gradually becomes a general view that the maximal size of pro-
tein to diﬀuse through the nuclear pore is around 60 kDa. The
demonstration in this study that the NPC allows diﬀusion of
proteins of various sizes larger than 60 kDa signiﬁcantly ex-
tends the diﬀusion limit set by the nuclear pore. It suggests that
many proteins do not require a nuclear localization/export sig-
nal to diﬀuse through the nuclear pore, which may be regarded
unlikely before. Accordingly, this study may explain the obser-
vations of the carrier and energy independent nuclear translo-
cation of some molecules, such as GFP-ERK2 (70 kDa)
[21,22]. On the other hand, the demonstrations of interaction
between ERK2 and nucleoporins in those studies suggest that
the protein diﬀusion through the nuclear pore could be further
aided by the protein interaction with nuclear pore components.
Interestingly, although it has been frequently demonstrated
that BSA is transported into the nucleus in a very poor man-
ner, the size of BSA is estimated be around 7 nm [6,30], which
is still less than the maximal size (9–12 nm) that is generally be-
lieved as the diﬀusion limit of the NPC (9–12 nm). This sug-
gests that other factors besides the protein size may
contribute to BSA cytoplasmic retention. On the other hand,
at the time when those studies were performed, the nuclear
translocation/export mechanism of the cells was very poorly
understood. For example, it has not been addressed whether
these proteins contain an NES. In fact, the issue of whether
the proteins contain an NLS/NES was not generally realized
and was neglected in most protein nuclear translocation stud-
ies before the mid 1980s. In addition, several factors may par-
ticipate in inﬂuencing protein cellular localization and
contribute to the discrepancies of the diﬀusion size among dif-
ferent proteins: (1) by forming dimer or oligomer complexes
between individual subunits; (2) protein compartmentalized
retention caused by forming a complex with other proteins
or other high order structures, such as cytoskeleton; (3) phys-
ical compatibility between nuclear pore components and theprotein to be transported, such as charges and hydrophobicity.
Furthermore, the cellular localization of protein may be com-
plicated by: (1) the association with other proteins that under-
go nuclear import/export; (2) the nucleus/cytoplasm-associated
protein degradation.
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